Cynthia Lynn Anderson

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Cynthia Anderson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cynthia Lynn Anderson:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vistagen Therapeutics, Inc. CHIEF FINANCIAL OFFICER Common Stock 12,801 $21,761 $1.70 30 Jun 2025 Direct
Vistagen Therapeutics, Inc. CHIEF FINANCIAL OFFICER Stock Option (Right to Buy) 100,000 23 Jun 2025 Direct

Insider Reports Filed by Cynthia Lynn Anderson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VTGN Vistagen Therapeutics, Inc. 30 Jun 2025 1 +$11,249 4 CHIEF FINANCIAL OFFICER 01 Jul 2025, 17:49
VTGN Vistagen Therapeutics, Inc. 23 Jun 2025 1 $0 4 CHIEF FINANCIAL OFFICER 25 Jun 2025, 17:15
VTGN Vistagen Therapeutics, Inc. 31 Dec 2024 1 +$6,499 4 CHIEF FINANCIAL OFFICER 13 Jan 2025, 17:39
VTGN Vistagen Therapeutics, Inc. 28 Jun 2024 1 +$10,625 4 CHIEF FINANCIAL OFFICER 02 Jul 2024, 18:08
VTGN Vistagen Therapeutics, Inc. 24 Jun 2024 1 $0 4 CHIEF FINANCIAL OFFICER 26 Jun 2024, 21:30
VTGN Vistagen Therapeutics, Inc. 21 Aug 2023 1 $0 4 CHIEF FINANCIAL OFFICER 23 Aug 2023, 13:09
VTGN Vistagen Therapeutics, Inc. 21 Aug 2023 0 $0 3 CHIEF FINANCIAL OFFICER 23 Aug 2023, 13:08